The pharmaceutical industry has reinvented itself with biological medicines and has reduced healthcare costs for society with generics and biosimilars, but at the same time it has taken giant steps in personalized medicine and genomics. The challenge for this industry is to complete digitization, pervasively use advanced data analysis tools and collaborate on a holistic approach to the provision of health care.